MyStocks

MEMBER'S LOGINX

Remember Username
Keep me signed in

(Please do not use this option on a public machine)

Home
Research It
Compare Company
International - mnc pharma
GSK PHARMA - ADCOCK INGRAM (S. Africa)

GSK PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

Mail
Print
FaceBook
Twitter
Linked In
WhatsApp

GSK PHARMA Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

ADCOCK INGRAM (S. Africa)
Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

GSK PHARMA

ADCOCK INGRAM

EQUITY SHARE DATA
		GSK PHARMA Mar-19	ADCOCK INGRAM Jun-14	GSK PHARMA/ ADCOCK INGRAM	5-Yr Chart Click to enlarge
High	Rs	3,595	353	-
Low	Rs	1,253	255	-
Sales per share (Unadj.)	Rs	184.7	105.0	-
Earnings per share (Unadj.)	Rs	26.3	-26.5	-
Cash flow per share (Unadj.)	Rs	29.2	-21.9	-
Dividends per share (Unadj.)	Rs	20.00	0	-
Dividend yield (eoy)	%	0.8	0	-
Book value per share (Unadj.)	Rs	126.3	82.4	-
Shares outstanding (eoy)	m	169.40	168.78	-
Bonus/Rights/Conversions		-	-	-
Price / Sales ratio	x	13.1	2.9	453.7%
Avg P/E ratio	x	92.2	-11.5	-802.9%
P/CF ratio (eoy)	x	83.1	-13.9	-599.9%
Price / Book Value ratio	x	19.2	3.7	520.6%
Dividend payout	%	76.1	0	-
Avg Mkt Cap	Rs m	410,626	51,290	800.6%
No. of employees	`000	5.0	4.3	115.5%
Total wages/salary	Rs m	5,372	3,219	166.9%
Avg. sales/employee	Rs Th	6,306.7	4,129.2	152.7%
Avg. wages/employee	Rs Th	1,083.1	749.8	144.4%
Avg. net profit/employee	Rs Th	898.0	-1,040.5	-86.3%

INCOME DATA
Net Sales	Rs m	31,281	17,727	176.5%
Other income	Rs m	1,023	124	824.2%
Total revenues	Rs m	32,304	17,851	181.0%
Gross profit	Rs m	6,009	-3,072	-195.6%
Depreciation	Rs m	486	765	63.5%
Interest	Rs m	6	480	1.2%
Profit before tax	Rs m	6,540	-4,193	-156.0%
Minority Interest	Rs m	0	-12	0.0%
Prior Period Items	Rs m	0	0	-
Extraordinary Inc (Exp)	Rs m	287	0	-
Tax	Rs m	2,373	262	905.7%
Profit after tax	Rs m	4,454	-4,467	-99.7%
Gross profit margin	%	19.2	-17.3	-110.8%
Effective tax rate	%	36.3	-6.2	-580.7%
Net profit margin	%	14.2	-25.2	-56.5%

BALANCE SHEET DATA
Current assets	Rs m	20,061	12,983	154.5%
Current liabilities	Rs m	14,543	7,305	199.1%
Net working cap to sales	%	17.6	32.0	55.1%
Current ratio	x	1.4	1.8	77.6%
Inventory Days	Days	57	111	51.2%
Debtors Days	Days	14	124	11.3%
Net fixed assets	Rs m	14,343	7,568	189.5%
Share capital	Rs m	1,694	82	2,058.2%
"Free" reserves	Rs m	19,704	0	-
Net worth	Rs m	21,398	13,914	153.8%
Long term debt	Rs m	2	4,889	0.0%
Total assets	Rs m	39,113	26,284	148.8%
Interest coverage	x	1,091.0	-7.7	-14,109.7%
Debt to equity ratio	x	0	0.4	0.0%
Sales to assets ratio	x	0.8	0.7	118.6%
Return on assets	%	11.4	-15.2	-75.2%
Return on equity	%	20.8	-32.1	-64.8%
Return on capital	%	31.9	-19.8	-161.2%
Exports to sales	%	0	0	-
Imports to sales	%	0	0	-
Net fx	Rs m	-6,557	0	-

CASH FLOW
From Operations	Rs m	3,994	1,513	263.9%
From Investments	Rs m	-1,433	-465	308.5%
From Financial Activity	Rs m	-3,584	4,438	-80.8%
Net Cashflow	Rs m	-1,023	5,486	-18.7%

NM: Not Meaningful

Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.87 Rs / ZAR

Compare GSK PHARMA With: MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)

Compare GSK PHARMA With: SANOFI INDIA FRESENIUS KABI ONCO. ALKEM LABORATORIES FDC ABBOTT INDIA

Today's Market

Crucial Week Ahead for the Indian Stock Market(Momentum Moves)

The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.